Abstract
Chemotherapy-induced neuropathic pain (CNP) is the major dose-limiting factor in cancer chemotherapy. However, the mechanisms underlying CNP remain el......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
